Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Lixte Biotechnology Holdings, Inc. (LIXT) had Weighted-Average Shares Outstanding (Diluted) of 2.47M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.71M |
|
-- |
|
-- |
|
$0.71M |
|
$-0.71M |
|
$-0.00M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
2.47M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.47M |
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$1.51M |
|
-- |
|
-- |
|
$1.51M |
|
$0.36M |
|
-- |
|
-- |
|
$0.36M |
|
$-2.34M |
|
$1.16M |
|
$1.16M |
|
2.68M |
|
| Cash Flow Statement Financials | |
$-0.57M |
|
-- |
|
$0.91M |
|
$1.04M |
|
$1.38M |
|
$0.35M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
30.31% |
|
-61.21% |
|
-46.86% |
|
-61.21% |
|
$0.43 |
|
$-0.23 |
|
$-0.23 |
|